Related Experiment Video
Updated: Sep 25, 2025

07:04
Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
Published on: August 15, 2020
5.5K
Advances in Neurodegenerative Diseases
Vasileios Siokas1, Efthimios Dardiotis1
1Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly Biopolis, Mezourlo Hill, 41100 Larissa, Greece.
Neurology International
|April 25, 2022
Summary
Neurodegenerative disorders encompass diverse diseases with varied symptoms. Understanding these complex conditions is crucial for developing effective treatments.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Neurodegenerative disorders represent a broad category of diseases characterized by progressive loss of neuronal structure or function.
- These conditions manifest with a wide spectrum of clinical presentations, impacting various neurological systems.
Discussion:
- The underlying mechanisms of neurodegeneration are complex and multifactorial, often involving protein misfolding, aggregation, oxidative stress, and inflammation.
- Identifying common pathways and disease-specific targets is essential for therapeutic intervention.
Key Insights:
- Research highlights the heterogeneity of neurodegenerative diseases, necessitating tailored diagnostic and therapeutic approaches.
- Advances in genetic and molecular research are uncovering novel insights into disease pathogenesis.
Outlook:
- Future research will focus on early diagnosis, personalized medicine, and the development of disease-modifying therapies.
- Translational studies aim to bridge the gap between basic science discoveries and clinical applications for neurodegenerative conditions.
Related Concept Videos
Alzheimer's Disease: Overview
693
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
693
Parkinson's Disease: Overview
751
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
751
Alzheimer's Disease: Treatment
272
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
272
Dementia
188
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
188
Parkinson's Disease: Treatment
411
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
411
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K

